Siga Technologies (SIGA) Retained Earnings (2010 - 2025)
Siga Technologies (SIGA) posted Retained Earnings of -$43.1 million for Q4 2025, down 14.43% on a QoQ basis from -$37.6 million in Q3 2025, and down 88.59% year-over-year from -$377.6 million in Q4 2024.
Siga Technologies (SIGA) Retained Earnings (2010 - 2025) Analysis & Trends
Siga Technologies' Retained Earnings history runs 16 years deep, the most recent figure standing at -$43.1 million for Q4 2025.
- Quarterly Retained Earnings fell 88.59% year-over-year to -$43.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$43.1 million (down 88.59% YoY) and the FY2025 annual result came in at -$43.1 million, down 88.59% from the prior year.
- Retained Earnings was -$43.1 million for Q4 2025 at Siga Technologies, down from -$37.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$22.8 million in Q4 2024 and bottomed at -$119.2 million in Q3 2021.
- A 5-year average of -$68.0 million and a median of -$66.2 million in 2022 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 67.62% in 2025, while the deepest fall reached 88.59% in 2025.
- Siga Technologies' Retained Earnings stood at -$51.8 million in 2021, then fell by 23.26% to -$63.8 million in 2022, then surged by 38.96% to -$38.9 million in 2023, then jumped by 41.36% to -$22.8 million in 2024, then tumbled by 88.59% to -$43.1 million in 2025.
- Business Quant data shows SIGA's Retained Earnings at -$43.1 million in Q4 2025, -$37.6 million in Q3 2025, and -$31.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | -43.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -43.07 Mn |
| Sep 30, 2025 | -37.64 Mn |
| Jun 30, 2025 | -31.28 Mn |
| Mar 31, 2025 | -23.25 Mn |
| Dec 31, 2024 | -22.84 Mn |
| Sep 30, 2024 | -68.60 Mn |
| Jun 30, 2024 | -69.95 Mn |
| Mar 31, 2024 | -71.78 Mn |
| Dec 31, 2023 | -38.94 Mn |
| Sep 30, 2023 | -111.20 Mn |
| Jun 30, 2023 | -110.81 Mn |
| Mar 31, 2023 | -72.28 Mn |
| Dec 31, 2022 | -63.80 Mn |
| Sep 30, 2022 | -60.14 Mn |
| Jun 30, 2022 | -93.18 Mn |
| Mar 31, 2022 | -58.70 Mn |
| Dec 31, 2021 | -51.76 Mn |
| Sep 30, 2021 | -119.21 Mn |
| Jun 30, 2021 | -108.97 Mn |
| Mar 31, 2021 | -102.53 Mn |